Table 1.
Vaccine information and vaccination schedule
| Vaccine | Target agent | Form | Manufacturer | Weaning | Post‐weaning | Gilts | Pre‐farrowing | Post‐breeding | Whole herd | |
|---|---|---|---|---|---|---|---|---|---|---|
| 3 wk | 6 wk | |||||||||
| PARASAIL® | Haemophilus parasuis | Avirulent live | Newport Laboratories | X | X | |||||
| CircoFLEX® | Circovirus | Killed | Boehringer Ingelheim | X | ||||||
| MycoFLEX® | Mycoplasma hyopneumonia | Killed | Boehringer Ingelheim | X | ||||||
| Myco Shield® | M. hyopneumonia | Killed | Novartis | X | ||||||
| Pneumostar® SIV | SIV H1N1 and H3N2 | Killed | Novartis | X | X d | |||||
| Enterisol Ileitis | Lawsonia intracellularis | Attenuated | Boehringer Ingelheim | X | ||||||
| Parvo Shield® L5E | Parvovirus, 5 strains of Leptospira and Erysipelas | Killed | Novartis | X | X | |||||
| Prefarrow Shield® 9a | E. coli (K99, K88, 987P, F41), C. perfringens type C, Bordetella bronchiseptica, Pastruella multocidatypes A/D | Killed | Novartis | X | ||||||
| ProSystem® RCEb | Rotavirus G serotypes 5 and 4 of Serogroup A, C. perfringens Type C, E. coli (K99, K88, 987P, F41) | Modified live | Merck | X | ||||||
| Ingelvac® PRRSc | Porcine Reproductive and Respiratory Syndrome Virus | Modified live | Boehringer Ingelheim | X | ||||||
| PRRSd | Porcine Reproductive and Respiratory Syndrome Virus | Killed | Newport | X | ||||||
a
5 wk pre‐farrowing.
b
2 wk pre‐farrowing.
c
January and July.
d
April and October.
This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.